Life Sciences Real Estate

Independent insight into one of Europe’s fastest-growing real estate sectors.

Life sciences real estate has emerged as a leading growth sector, transforming from a niche asset class into a cornerstone of Europe's innovation economy. Investors, developers, and occupiers need clear analysis, reliable data, and a partner who understands both the science and the property.

Meet the founder

Stephen Ryan has spent more than three decades at the intersection of real estate, investment, and research. Before founding Life Sciences Real Estate, his roles included research and due diligence at INREV in Amsterdam, investment advice for institutional investors at Mercer, and investment product development at Irish Life Investment Managers and State Street Global Advisors.

In 2019, Stephen began applying natural language processing (NLP) and AI to research projects, unlocking insights from millions of words of unstructured data. By 2021, he was working with Trinity College Dublin on a pioneering project to analyse a database of more than 300 million words.

This blend of deep sector knowledge and cutting-edge data expertise is what makes Life Sciences Real Estate unique.

Our services

We provide three core services:

Weekly research: independent analysis covering deals, market trends, and sector developments across Europe's life sciences property markets.

Data tools: interactive intelligence platforms including our deals database, plus two new tools coming soon: LabSpace UK (comprehensive UK lab directory) in Q4 2025 and Reuse Europe (building conversion tracker) in Q1 2026.

Bespoke research: custom market analysis and consulting projects tailored to investor, developer, and occupier needs.

We also contribute insights at industry conferences and forums across Europe, sharing expertise with the broader life sciences real estate community.

👉 Subscribe to our weekly analysis | Explore our data tools | Discuss a research project